, Volume 28, Issue 4, pp 200-206

Effects of thiazolidinediones on cardiovascular risk factors

Rent the article at a discount

Rent now

* Final gross prices may vary according to local VAT.

Get Access

Abstract

The thiazolidinediones are the insulin sensitizers used in the management of Type 2 diabetes mellitus. These drugs can potentially decrease the risk of cardiovascular disease by correcting the different components of the insulin resistance syndrome.

The authors have stated that they do not have a significant financial interest or other relationship with any product manufacturer or provider of services discussed in this article.